News & Analysis as of

Pharmaceutical Industry › Directors

Seyfarth Shaw LLP

Another Caremark Duty-to-Monitor Suit Survives Motion to Dismiss in Delaware

Seyfarth Shaw LLP on

Seyfarth Synopsis: The Delaware Chancery Court’s October 1 In re Clovis decision marks the second time in 2019 that a Delaware court has permitted a Caremark duty-to-monitor derivative claim against directors—considered...more

Katten Muchin Rosenman LLP

Delaware Court Denies Dismissal for Disinterested Directors When Entire Fairness Applies

Katten Muchin Rosenman LLP on

The Delaware Court of Chancery recently addressed the pleading standard for claims against disinterested directors arising out of transactions involving a controlling stockholder, where the transaction has been alleged to be...more

2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide